Wall Street Zen upgraded shares of Archer Daniels Midland (NYSE:ADM – Free Report) from a buy rating to a strong-buy rating in a research note released on Saturday morning,Wall Street Zen reports. Other analysts have also recently issued research reports about the company. Zacks Research cut Archer Daniels Midland from a “strong-buy” rating to a […]

Wall Street Zen downgraded shares of CTO Realty Growth (NYSE:CTO – Free Report) from a hold rating to a sell rating in a research note released on Saturday,Wall Street Zen reports. Several other research analysts have also recently weighed in on CTO. Zacks Research cut shares of CTO Realty Growth from a “strong-buy” rating to […]

Wall Street Zen upgraded shares of Ciena (NYSE:CIEN – Free Report) from a hold rating to a buy rating in a research report released on Sunday morning,Wall Street Zen reports. CIEN has been the subject of a number of other research reports. TD Cowen reissued a “buy” rating on shares of Ciena in a research […]

Wall Street Zen downgraded shares of WisdomTree (NYSE:WT – Free Report) from a buy rating to a hold rating in a research note published on Saturday morning,Wall Street Zen reports. Other equities analysts have also issued reports about the company. Morgan Stanley upped their target price on WisdomTree from $21.00 to $27.00 and gave the […]

Wall Street Zen upgraded shares of Brink’s (NYSE:BCO – Free Report) from a hold rating to a buy rating in a research note released on Saturday,Wall Street Zen reports. Separately, Weiss Ratings downgraded Brink’s from a “hold (c+)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Two research analysts […]

Wall Street Zen cut shares of Ross Stores (NASDAQ:ROST – Free Report) from a buy rating to a hold rating in a report published on Saturday morning,Wall Street Zen reports. A number of other analysts have also recently commented on ROST. Wolfe Research assumed coverage on shares of Ross Stores in a research note on […]

Castle Biosciences (NASDAQ:CSTL – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday, Wall Street Zen reports. Other equities analysts have also recently issued reports about the company. Weiss Ratings upgraded Castle Biosciences from a “sell (e+)” […]

Wall Street Zen downgraded shares of CVS Health (NYSE:CVS – Free Report) from a strong-buy rating to a buy rating in a report issued on Monday,Wall Street Zen reports. Other research analysts have also recently issued reports about the stock. Truist Financial lifted their price target on shares of CVS Health from $108.00 to $118.00 […]